Dual Costimulatory Blockade Improves Immunosuppression as a Non-Calcineurin Option in Kidney Transplantation: Study
USA: A phase 2a pilot trial evaluating dual costimulatory blockade with dazodalibep plus belatacept suggests this approach may improve immunosuppression adherence and offer a non-calcineurin alternative for kidney transplant recipients.…